Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2

Hypertension

Volumn 33, Issue 2, 1999, Pages 703-707

  Davies, Eleanor ^a   Holloway, Christine D ^a   Ingram, Mary C ^a   Inglis, Gordon C ^a   Friel, Elaine C ^a   Morrison, Caroline ^b   Anderson, Niall H ^a   Fraser, Robert ^a   Connell, John M C ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Aldosterone; Binding sites; Blood pressure; Intronic conversion; Polymorphism; SF 1

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; RENIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL;

EID: 0033034853     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.2.703     Document Type: Article

References (28)

1. de Macedo MG, Trigueriros D, Freitas AF. Aggregation of blood pressure in families: genetic and environmental influences. J Hum Hypertens. 1990;4:303-306.
2. Williams RR, Hunt SC, Hasstedt SJ, Hopkins PN, Wu LL, Berry TD, Stults BM, Barlow GK, Kuida H. Genetics of hypertension: what we know and what we don't know. Clin Exp Hypertens. 1990;A12:865-876.
3. Watt GCM, Harrap SG, Foy CJW, Holtan DW, Edwards HV, Davidson HR, Connor JM, Lever AF, Fraser R. Abnormalities of glucocorticoid metabolism and renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens. 1992;10:473-482.
4. Edwards CRW, Carey RM, eds. Essential Hypertension as an Endocrine Disease. London, UK: Butterworths; 1985.
5. Vallotton MB. Primary aldosteronism, part I: diagnosis of primary hyperaldosteronism. Clin Endocrinol. 1996;45:47-52.
6. Vallotton MB. Primary aldosteronism, part II: differential diagnosis of primary hyperaldosteronism and pseudoaldosteronism. Clin Endocrinol. 1996;45:53-60.
7. Beretta-Piccoli C, Davies DL, Boddy K, Brown JJ, Cumming AMM, East BW, Fraser R, Lever AF, Padfield PL, Semple PF, Robertson JIS, Weidmann P, Williams ED. Relation of arterial blood sodium, body potassium and plasma potassium in essential hypertension. Clin Sci. 1982;63:257-270.
8. Walker BR, Padfield PL. Renin subgroups in hypertension. In: Swales JD, ed. Textbook of Hypertension. London, UK: Blackwell; 1994: 735-740.
9. Wisgerhof M, Brown RD. Increased adrenal sensitivity to angiotensin II in low renin hypertension. J Clin Invest. 1978;61:1456-1462.
10. Fraser R, Beretta-Piccoli C, Brown JJ, Cumming AMM, Lever AF, Mason PA, Morton JJ, Robertson JIS. Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension. Conn's syndrome and nontumorous hyperaldosteronism. Hypertension. 1981;3(Part 2):I-87-I-92.
11. Griffing GT, Wilson TE, Melby JC. Alterations in aldosterone secretion and metabolism in low renin hypertension. J Clin Endocrinol Metab. 1990;71:1454-1460.
12. Parker KL, Schimmer BP. Transcriptional regulation of the genes encoding the cytochrome P450 steroid hydroxylases. Vitam Horm. 1995; 51:339-370.
13. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM. A chimaeric 11beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992;355:262-265.
14. Honda S, Morohashi K, Nomura M, Takeya H, Kitajima M, Omwa T. Ad4BP regulating steroidogenic P450 gene is a member of the steroid hormone receptor super family. J Biol Chem. 1993;268:7494-7502.
15. Ikeda Y, Lala DS, Luo X, Kim E, Moisan MP, Parker KL. Characterization of the mouse FTZ-F1 gene, which encodes a key regulator of steroid hydroxylase gene expression. Mol Endocrinol. 1993;7:852-860.
16. Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H, White PC. Association between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass and function. Circulation. 1998;97:569-575.
17. White PC, Slutsker L. Haplotype analysis of CYP11B2. Endocr Res. 1995;21:437-442.
18. Shacklelon CHL. Mass spectrometry: application to steroid and peptide research. Endocr Rev. 1985;6:441-486.
19. Fleiss JL. Statistical Methods for Rates and Proportions. New York: Wiley; 1981.
20. Terwilliger JD, Ott J. Handbook of Human Genetic Linkage. Baltimore, MD: John Hopkins University Press; 1994.
21. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
22. Soubrier F, Jeunemaitre X, Rigat B, Houot AM, Cambien F, Corvol P. Similar frequencies of renin gene restriction fragment length polymorphisms in hypertensive and normotensive patients. Hypertension. 1990;16:712-717.
23. Naftilan AJ, Williams R, Burt D, Paul M, Pratt RE, Hobart P, Chirgwin J, Dzau VJ. A lack of genetic linkage of renin gene restriction fragment length polymorphisms with human hypertension. Hypertension. 1989;14: 614-618.
24. Schmidt S, van Hooft IMS, Grobbe DE, Ganten D, Ritz E. Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch hypertension and offspring study. J Hypertens. 1993;11:345-348.
25. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet. 1992;1:72-75.
26. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJW, Watt GCM. The angiotensin 1 converting enzyme gene and predisposition to high blood pressure. Hypertension. 1993;21: 455-460.
27. Benetos A, Poirier O, Guyene TT, Pojaga L, Cambien F. Genetic determination of plasma aldosterone levels. Hypertension. 1997;30:P66. Abstract.
28. Litchfield WR, Hunt SC, Jeunemaitre X, Fisher NDL, Hopkins PN, Williams RR, Corvol P, Williams GH. Increased urinary free cortisol: a potential intermediate phenotype of essential hypertension. Hypertension. 1998;31:569-574.